Christoph Bock is Principal Investigator at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and Professor of [Bio]Medical Informatics at the Medical University of Vienna. His research combines experimental biology (high-throughput sequencing, epigenetics, CRISPR screening, synthetic biology) with computational methods (bioinformatics, machine learning, artificial intelligence) – for cancer, immunology, and precision medicine. 

  

Before coming to Vienna, he was a postdoc at the Broad Institute of MIT and Harvard (2008-2011), and a PhD student at the Max Planck Institute for Informatics (2004-2008). Christoph is also scientific coordinator of the Biomedical Sequencing Facility of CeMM and MedUni Vienna, informatics group leader at the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases (LBI-RUD), and fellow of the European Lab for Learning and Intelligent Systems (ELLIS). 

  

Christoph is an elected member of the Young Academy of the Austrian Academy of Sciences, recipient of several research awards including the Otto Hahn Medal of the Max Planck Society (2009), an ERC Starting Grant (2016-2021), an ERC Consolidator Grant (2021-2026), and the Overton Prize of the International Society for Computational Biology (2017), and co-founder of Myllia Biotechnology, a Vienna-based biotech company that develops and applies single-cell methods for drug discovery.